Daily Archives: January 8, 2019

HR Thought Leader Josh Bersin Joins Virgin Pulse CEO Advisory Board

PROVIDENCE, R.I., Jan. 08, 2019 (GLOBE NEWSWIRE) — Virgin Pulse, the largest global employee health and wellbeing company, today announced that renowned HR technology analyst and influencer Josh Bersin, has joined Virgin Pulse’s CEO Advisory Board. In this capacity, Bersin will

DoubleVerify Partners with MoPub to Combat Mobile Ad Fraud

Partnership extends DV fraud coverage across MoPub’s mobile app exchange NEW YORK, Jan. 08, 2019 (GLOBE NEWSWIRE) — DoubleVerify (“DV”), the leading independent provider of marketing measurement software and analytics, today announced a partnership with MoPub, a leading provider of

Quantenna’s Spartan Architecture Brings High-Capacity Mesh Wi-Fi to TIME’s Malaysian Customers

LAS VEGAS, Jan. 08, 2019 (GLOBE NEWSWIRE) — Quantenna Communications, Inc. (NASDAQ : QTNA) announced today that Quantenna’s QV860 chipset is powering TIME dotCom’s latest dual-band dual concurrent mesh extender, the WiFi Booster. Based on the AirTies Air 4830, the

Infovista names José Duarte as Chief Executive Officer

Newly appointed CEO to strengthen position for next stage of growth and scale PARIS and ASHBURN, Va., Jan. 08, 2019 (GLOBE NEWSWIRE) — Infovista, the leader in modern network performance, today announced that its Board of Directors has appointed José

LeddarTech Joins Baidu’s Apollo Autonomous Driving Open Platform

LeddarTech joins Baidu’s Apollo autonomous driving open platform with its LiDAR products through an open source SDK QUEBEC CITY, Jan. 08, 2019 (GLOBE NEWSWIRE) — LeddarTech, an industry leader providing the most versatile and scalable auto and mobility LiDAR platform,

Lupin Limited: Orphan Drug NaMuscla® Receives European Commission Approval for the Treatment of Myotonia in Non-Dystrophic Myotonic Disorders

Orphan Drug NaMuscla® Receives European Commission Approval for the Treatment of Myotonia in Non-Dystrophic Myotonic Disorders Zug, Switzerland, 8 January 2019: Lupin is pleased to announce that the European Commission (EC) has approved NaMuscla® (mexiletine) for the symptomatic treatment of

Nanobiotix and MD Anderson Cancer Center announce a large-scale, comprehensive clinical collaboration on NBTXR3

Collaboration will initially support nine new phase I/II clinical trials with Nanobiotix’s first-in-class agent NBTXR3 for use in treating six cancer types – head and neck, pancreatic, thoracic, lung, gastrointestinal and genitourinary cancers – involving around 340 patients Most of

Royal Government Supports Natural Resource Preservation in Preah Vihear

The Royal Government of Cambodia, through the Ministry of the Environment, has donated US$20,000 to Mr. Ben Davis, a conservationist, to support his efforts in protecting and conserving forest resources and wildlife in Phnom Thnot-Phnom Pork Wildlife S...

Royal Government Supports Natural Resource Preservation in Preah Vihear

The Royal Government of Cambodia, through the Ministry of the Environment, has donated US$20,000 to Mr. Ben Davis, a conservationist, to support his efforts in protecting and conserving forest resources and wildlife in Phnom Thnot-Phnom Pork Wildlife S...

Cambodia Opens for All Investments

Cambodia has been practicing free economy and opening for investments from all countries, claimed the country's senior official.H.E. Sok Chenda Sophea, Minister attached to the Prime Minister and Secretary General of the Council for the Development of ...